PINT has released a redesigned site for MultiCell Technologies Inc. (OTCBB: MUCL). The new website represents the public Company's evolved structure as a merged entity and the Company's current technology focus. The revised website will attract new investors and partners to finance continued growth, and increase exposure to key audiences. The new URL will shortly become www.MultiCellTech.com, but the site can also be reached through the former URLs - www.multicelltechnologies.com and www.exten.com.

W. Gerald Newmin, MultiCell's Chairman, Chief Executive Officer, and President, stated, "We are very pleased to have finally completed our new website and welcome any comments. We hope shareholders and anyone interested in MultiCell will find this site eminently more timely and navigable that our old site. We shall continue to add information in a timely manner."

About MultiCell Technologies, Inc.
MultiCell Technologies, formerly Exten Industries, provides non-tumorigenic functional hepatic (liver) cells and cell lines to pharmaceutical companies for induction studies as well as toxicity screening for drug discovery.